WHAT WE DO


NirvaMed Inc. is a pioneering medical device startup focused on developing advanced treatments for heart conditions. 



Our groundbreaking therapy aims to improve patient outcomes significantly. 






EXPANDING OUR HORIZONS


While we continue our commitment to developing heart cooling solutions for ST-Elevation Myocardial Infarction (STEMI) heart attacks, our revised business strategy now also includes a focus on the complex percutaneous coronary intervention (PCI) market. 


This dual market approach allows us to address critical needs in cardiology with innovative solutions.







ADVANCING



NirvaMed is actively raising the next financing.


These funds will further develop our new catheter technology, advance product development, conduct clinical studies, and pursue 510(k) clearance within four years. 


This new catheter not only supports our original STEMI focus but also opens new opportunities in the complex PCI market. 







STRATEGIZING



We have strategically relocated our research operations to Thailand to leverage untapped resources and reduce costs. 


Simultaneously, we maintain a strong presence in Minnesota, the center of the medical device industry. Our ongoing collaboration with the Visible Heart Lab at the University of Minnesota exemplifies our dual-location strategy


 


IMPACTING THAI MEDICAL INNOVATION


NirvaMed is proud to act as a bridge between Thailand and the US, bringing Thai talent into the global med-tech community.

 With support from Siriraj Medical School, we hosted Thai medical interns and fellows on our research trip to Minnesota, providing hands-on experience and valuable industry exposure 

 NirvaMed is committed to our mission to nurture Thai medical innovation and create impactful opportunities.